- Home
- ITOC vs HSCS Comparison
ITOC vs HSCS Comparison
Compare ITOC & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ITOC | HSCS |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | China | United States |
| Employees | 7 | 12 |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 6.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ITOC | HSCS |
|---|---|---|
| Price | $0.33 | $2.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 152.3K | ★ 4.7M |
| Earning Date | 03-20-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $1.63 |
| 52 Week High | $1.15 | $4.33 |
Technical Indicators
Market Signals| Indicator | ITOC | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 57.44 |
| Support Level | $0.28 | $2.61 |
| Resistance Level | $0.34 | $3.18 |
| Average True Range (ATR) | 0.02 | 0.41 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 25.31 | 48.77 |
Price Performance
Historical ComparisonAbout ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.